MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels
XX
BSO - Titre
Brief report: MET exon 14 alterations and new resistance-mutations to tyrosine kinase inhibitors: risk of inadequate detection with current amplicon-based NGS panels
